Make your money go further for just 25p per day

AIM IHT

Vaccine countdown update: 20 Nov - our Bonkers Bargain attracts interest

Mulberry tree

Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full acquisition. Read on for our thoughts on this and other updates here.


Fusion Antibodies: results underwhelm

Fusion Antibodies (LON: FAB), specialists in pre-clinical antibody discovery, for both therapeutic drug and diagnostic applications, underwhelmed with its interim results for the six months ending 30 September 2020, at least for a business with its high rating – the current market capitalisation is £29m.

Revenues rose 8.5% of £1.90m with losses remaining stable at £0.47m.

They expanded their R&D programme in the period by 50% to £271k to include a COVID-19 target…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Advanced Medical Solutions

Gold winner | Entrepreneurial success | CEO suspension

19/03/2025 · Company Insights

There are plenty of excellent results from AIM covered here, but we are surprised a pawnbroker…


Medical advances | Stonking Small Cap update | Measured growth

15/01/2025 · Company Insights

News covered here includes our assessment of excellent results from a diversified financial services provider and…


More on Argentex Group PLC

Bonkers Bargain drama | Accounting manoeuvres | Automotive excellence

24/04/2025 · Company Insights

AIM investors returning from their Easter break were ‘welcomed’ back with dramatic news from one of…


Bonkers Bargains: reset is starting to deliver

02/04/2025 · Company Insights

A new management team is executing its plan to accelerate growth in this expert in currency risk management…


More on Frasers Group

10% dividend yield | Another brand buy | Frasers falls

06/12/2024 · Company Insights

News covered here incudes our assessment of results from a lowly valued UK fund manager, whose…


AIM takeovers | Automotive excellence and struggles

01/10/2024 · Company Insights

One of AIM’s largest companies seems inclined to accept a private equity funded offer, with an…


More on Fusion Antibodies PLC

Vaccine countdown update: 20 Nov - our Bonkers Bargain attracts interest

20/11/2020 · Company Insights

Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full…


Coronavirus impact: 28 April - soaring share prices from this little lot

28/04/2020 · Company Insights

Announcements included an update from from Burford Capital, which saw its shares bounce strongly, but we still…


More Company Insights

Big Buyback | Cosmetic growth | Back in tune?

29/04/2025 · Animalcare · Focusrite · Jet2 · Warpaint London

Fast-growing consulting firm delivers excellent results

28/04/2025 · Elixirr International

Cladding delivers | CEO clears the decks | Nice price

Sign-up to our free email updates

SIGN UP